COMMUNIQUÉS West-GlobeNewswire

Fangzhou Honored with Digital Intelligence Leadership Award at Tencent Summit, Expands Healthcare AI Partnership with Tencent Health
30/10/2026
SHANGHAI, Oct. 30, 2026 (GLOBE NEWSWIRE) -- Fangzhou Inc. (“Fangzhou” or the “Company”) (HKEX: 06086), a leading provider of AI‑driven Internet healthcare solutions, received the “Digital-intelligence Leadership Award- [...]
Vivoryon Therapeutics N.V. to Report Q3 2026 Financial Results on November 5, 2026
30/10/2026
Vivoryon Therapeutics N.V. to Report Q3 2026 Financial Results on November 5, 2026 Halle (Saale) / Munich, Germany, October 30, 2026 - Vivoryon Therapeutics N.V. (Euronext Amsterdam: VVY; NL00150002Q7) ( Vivoryon ), a [...]
Evaxion receives International Prix Galien Award for AI-Immunology™ as best digital health solution
30/10/2026
This international award, honoring “the best of the best” in medical innovation, represents yet another important external recognition of AI-Immunology™ COPENHAGEN, Denmark, October 30, 2026 - Evaxion A/S (NASDAQ: EVAX [...]
2026 InLight Foundation Stanford Frontier Dialogue: From Nobel Optogenetics to Mind-Light Contemplation, Cross-Disciplinary Experts Explore New Frontiers in Consciousness Regulation
30/10/2026
PALO ALTO, Calif., Oct. 29, 2026 (GLOBE NEWSWIRE) -- Following the awarding of the 2026 Nobel Prize in Physiology or Medicine to pioneers in optogenetics, the InLight Foundation concluded its "Consciousness and Science [...]
InnoCare Announces First Subject Dosed in Clinical Trial of TL1A/IL-23p19 Bispecific Antibody ICP-B161 in China
30/10/2026
BEIJING, Oct. 30, 2026 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that the first [...]
Aspen Neuroscience Announces Pricing of Initial Public Offering
30/10/2026
SAN DIEGO, Oct. 29, 2026 (GLOBE NEWSWIRE) -- Aspen Neuroscience, Inc. (Nasdaq: ASPE), a clinical-stage regenerative medicine biotechnology company developing autologous cell therapies for Parkinson’s disease (PD), today [...]
Nephros Schedules Third Quarter 2026 Financial Results Conference Call
29/10/2026
SOUTH ORANGE, N.J., Oct. 29, 2026 (GLOBE NEWSWIRE) -- Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced that it will [...]
Tarsus to Report Third Quarter 2026 Financial Results on Tuesday, November 3, 2026
29/10/2026
IRVINE, Calif., Oct. 29, 2026 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), today announced that it will host a live webcast at 1:30 p.m. PT / 4:30 p.m. ET on Tuesday, November 3, 2026 to report its [...]
Cytek Biosciences to Participate in Upcoming Investor Conferences
29/10/2026
FREMONT, Calif., Oct. 29, 2026 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the company will be participating in the following investor [...]
Seer to Remain an Independent Public Company Following Conclusion of Special Committee Review Process
29/10/2026
REDWOOD CITY, Calif., Oct. 29, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced that the Special Committee of Seer’s Board of [...]
Avicanna Announces Closing of Non-Brokered Private Placement of Non-Convertible Debenture Units
29/10/2026
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAWS TORONTO, Oct. 29 [...]
SI-BONE To Present at UBS Global Healthcare Conference on November 10, 2026
29/10/2026
SAN JOSE, Calif., Oct. 29, 2026 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), the global leader in developing procedural solutions to address clinical challenges associated with compromised bone, today announced [...]
OSE Immunotherapeutics annonce des résultats positifs complémentaires de l'étude de Phase 2 randomisée Combi-TED de Tedopi® (OSE2101) dans le cancer du poumon non à petites cellules métastatique
29/10/2026
Résultats finaux positifs pour le critère principal et plusieurs critères secondaires présentés par le Pr Federico Cappuzzo, PhD, le 25 octobre 2026 au congrès annuel de l’ European Society for Medical Oncology (ESMO) à [...]
OSE Immunotherapeutics Reports Additional Positive Results of Combi-TED Phase 2 Randomized Trial with Tedopi® (OSE2101) in metastatic Non-Small Cell Lung Cancer
29/10/2026
Final positive readout for primary and several secondary endpoints presented by Federico Cappuzzo, MD, PhD, on October 25, 2026, at the Annual Meeting of the European Society for Medical Oncology (ESMO) in Madrid 12- [...]
Cedar Park Packs the Parking Lot for Ally Medical ER’s Official Ribbon Cutting
29/10/2026
Neighbors, families, and community leaders filled the parking lot of the newest Ally Medical ER for an evening of food, games, and celebration CEDAR PARK, Texas, Oct. 29, 2026 (GLOBE NEWSWIRE) -- Ally Medical Emergency [...]
Mdxhealth to Release Third Quarter 2026 Financial Results on November 12
29/10/2026
Company to Host Conference Call with Live Q&A, November 12, 2026, at 4:30pm ET / 22:30 CET IRVINE, California – October 29, 2026 ( GlobeNewswire ) – Mdxhealth SA (NASDAQ: MDXH), a leading precision diagnostics [...]
Assembly Biosciences Doses First Two Participants in Phase 2 Study of Oral NTCP Inhibitor ABI-6250 for Chronic Hepatitis Delta Virus
29/10/2026
– Phase 2 study will evaluate the safety, pharmacokinetics and antiviral activity of ABI-6250 in participants with chronic HDV infection – – Initial data from the Phase 2 study is expected in the fourth quarter of 2027 [...]
NRx Pharmaceuticals (Nasdaq: NRXP) to Host Conference Call on October 30, 2026 to Discuss Regulatory Milestone for Preservative-Free Ketamine
29/10/2026
Company to issue press release before market open; conference call to follow at 8:30 a.m. ET WILMINGTON, Del., Oct. 29, 2026 (GLOBE NEWSWIRE) -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP, “NRx” or “the Company”), a [...]
MannKind to Report Third Quarter Financial Results and Host Conference Call on November 5, 2026
29/10/2026
DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Oct. 29, 2026 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) announced today that it will report third quarter 2026 financial results after market close on Thursday [...]

Pages

Other news

Test 2

22/10/2026

Lorem ipsum

Test 1

22/10/2026

Lorem upsum